• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. UNK FENIX MAGNETIC IMPLANT; IMPLANTED FECAL INCONTINENCE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. UNK FENIX MAGNETIC IMPLANT; IMPLANTED FECAL INCONTINENCE DEVICE Back to Search Results
Catalog Number UNK FENIX MAGNETIC IMPLANT
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191); Patient Device Interaction Problem (4001)
Patient Problems Erosion (1750); Hypersensitivity/Allergic reaction (1907); Unspecified Infection (1930); Pain (1994); Blood Loss (2597); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Event years are between 2008 and 2011, batch # unknown.This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot/batch number has not been provided.As the device was not returned, an analysis investigation could not be performed.A conclusion could not be reached as to what may have caused or contributed to the event.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the author/surgeon believe that the ethicon device caused or contributed to the patient complications mentioned in the article? if yes, please explain.Please provide the specific number of patients who experienced implant site pain, device erosion, implant site infection, bleeding, allergic reaction.
 
Event Description
It was reported via journal article: title: long-term experience of magnetic anal sphincter augmentation in patients with fecal incontinence.Authors: jeremy sugrue, m.D.; paul-antoine lehur, m.D., ph.D.; robert d.Madoff, m.D.; shane mcnevin, m.D.; steen buntzen, m.D., ph.D.; søren laurberg, m.D., ph.D.; anders mellgren, m.D., ph.D.Citation: dis colon rectum.2017; 60: 87¿95.Doi: 10.1097/dcr.0000000000000709.Magnetic anal sphincter augmentation is a novel technique of patients with fecal incontinence.The objectives of this prospective multicenter pilot study was to report the long-term effectiveness and safety of this new treatment modality.The cohort included patients with severe fecal incontinence for 6 months who had previously failed conservative therapy and were implanted with a magnetic anal sphincter device between 2008 and 2011.A total of 35 patients (1 male and 34 female patients; age range: 41 to 77 years old) were included in the study.The fenix mas device (ethicon) device is a ring of magnetic beads that is surgically implanted around the anal canal and is designed to reinforce weakened anal sphincter muscles.It consists of a permanent implant that is designed to treat fl by reinforcing weakened anal sphincter muscles.During the procedure, a sizing tool was placed into the tunnel, allowing for measurement to determine the proper size of the mas device.The properly sized mas device was then placed into the tunnel and a fluoroscopic image was taken to confirm proper placement.Reported complications included infection (n-3) which require device removal, device erosion (n-3) which require device removal , lack of efficacy (n-1) which require device removal, defecatory dysfunction (n-8) which required no or minimal interventions, such as medications, diet modification and occasional enemas and suppositories in 7 patients and stoma creation without device removal in 1 case, implant site pain (14%) which required no or minimal interventions, such as medication, device erosion (11%) which required no or minimal interventions, such as medication, implant site infection (11%) which required no or minimal interventions, such as medication, bleeding (9%) which required no or minimal interventions, such as medication, allergic reaction (3%) which required no or minimal interventions, such as medication.This is the first study to present long-term safety and efficacy data for the mas device for the treatment of fi.The study demonstrates that mas provided excellent outcomes in patients who retained a device at long-term follow-up.The present study shows that the decrease in fi symptoms after mas device implantation translated into an improvement in quality of life at long-term follow-up in patients who kept their device, as measured by the fiqol instrument.The safety of the mas device is of utmost importance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK FENIX MAGNETIC IMPLANT
Type of Device
IMPLANTED FECAL INCONTINENCE DEVICE
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
kara ditty-bovard
4188 lexington avenue north
shoreview, MN 
6107428552
MDR Report Key10502055
MDR Text Key211687792
Report Number3008766073-2020-00140
Device Sequence Number1
Product Code PMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue NumberUNK FENIX MAGNETIC IMPLANT
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/13/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-